ICON shares up 4% on profit leap
ICON, which tests and researches drugs and equipment for pharmaceutical and medical device firms, saw profits rise to $55.9 million (€37.7m) from $38m in the previous year.
Revenues for the year rose by 38% to $630m and the company said it won $344m of new business in the final quarter of 2007.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





